← Leaderboards
Ramin M. Hakami
Integrated Biotherapeutics, Inc.
$1,186,166
Attributed
$3,558,497
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1000K · FY2017–21$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,558,497 · 2
By mechanism
R42$2,963,566 · 1
R41$594,931 · 1
Top collaborators
- Rajan P Adhikari6 shared
- Daniel C. Nelson6 shared
Most similar at Integrated Biotherapeutics, Inc.
Same institution · by research overlap
- Rajan P Adhikari$2,976,940
Others in their field
Other Emerging Leaders on “Bioterrorism”
- Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn$49,622,217
- Lori Dodd · Leidos Biomedical Research, Inc.$9,824,009
- Gary Kobinger · University Of Texas Med Br Galveston$7,131,815
- Farhang Alem · George Mason University$6,647,226
- Gene Tan · J. Craig Venter Institute, Inc.$5,686,063
- Karen Marie Dobos · Colorado State University$3,193,195
Research focus
BioterrorismCellsBacteriophagesBindingCartoonsCatalytic DomainAerosolizedBactericideBacterial ToxinsBaseAdverse EffectsAnthrax VaccinesAntibioticsAntibiotic TherapyAntibodiesAnimalsAnthrax DiseaseAntigensAnthrax Lethal FactorBacillus Anthracis SporeAffinityBacteriaBacillus AnthracisCell Wall
Grant awards (6)
Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis$663,271
R42 · FY2021 · AI
Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis$315,000
R42 · FY2021 · AI
Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis$985,298
R42 · FY2020 · AI
Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis$999,997
R42 · FY2019 · AI
Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis$299,999
R41 · FY2018 · AI
Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis$294,932
R41 · FY2017 · AI